Shepard Jay
Insider CIK 1587788 · INO Director · DRRX Director · MRNS Director · ESPR Director · IRWD Director · VSAR President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 32,500 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 44,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 21,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer | 2026-07-13 | 2026-07-13 | 164,472 | — | $0 | 0 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2026-06-16 | 2026-06-17 | 63,481 | — | $0 | 235,036 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2026-05-28 | 2026-06-01 | 79,873 | — | $0 | 164,472 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 34,200 | — | $0 | 34,200 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 41,800 | — | $0 | 41,800 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2025-06-10 | 2025-06-12 | 45,000 | — | $0 | 171,555 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2025-05-29 | 2025-06-02 | 33,000 | — | $0 | 84,599 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-05-21 | 2025-05-21 | 2,167 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-05-21 | 2025-05-21 | 2,167 | — | $0 | 9,209 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2024-06-18 | 2024-06-21 | 24,311 | — | $0 | 126,555 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-24 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2024-05-23 | 2024-05-24 | 23,000 | — | $0 | 51,599 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-05-21 | 2024-05-22 | 2,167 | — | $0 | 2,167 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-05-21 | 2024-05-22 | 2,917 | — | $0 | 2,917 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-15 | 2024-05-16 | 2,166 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-05-15 | 2024-05-16 | 2,166 | — | $0 | 7,042 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2023-06-20 | 2023-06-22 | 22,350 | — | $0 | 102,244 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2023-06-15 | 2023-06-16 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2023-06-15 | 2023-06-16 | 5,150 | — | $0 | 28,599 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-05-16 | 2023-05-16 | 19,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-05-16 | 2023-05-16 | 19,000 | — | $0 | 58,521 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-01-15 | 2023-01-17 | 4,273 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-01-15 | 2023-01-17 | 4,273 | — | $0 | 39,521 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2022-06-01 | 2022-06-03 | 21,571 | — | $0 | 79,894 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2022-05-26 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-16 | 2022-05-17 | 19,000 | — | $0 | 19,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-16 | 2022-05-17 | 28,000 | — | $0 | 28,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-05-13 | 2022-05-17 | 18,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-05-13 | 2022-05-17 | 18,000 | — | $0 | 35,248 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-01-15 | 2022-01-18 | 4,274 | — | $0 | 4,273 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-01-15 | 2022-01-18 | 4,274 | — | $0 | 17,248 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2021-06-02 | 2021-06-04 | 22,766 | — | $0 | 58,323 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-05-27 | 2021-05-28 | 12,376 | — | $0 | 23,449 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-05-14 | 2021-05-17 | 8,700 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-05-14 | 2021-05-17 | 8,700 | — | $0 | 12,974 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-05-13 | 2021-05-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-05-13 | 2021-05-17 | 27,000 | — | $0 | 27,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-01-15 | 2021-01-15 | 4,274 | — | $0 | 8,547 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-01-15 | 2021-01-15 | 4,274 | — | $0 | 4,274 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-12-03 | 2020-12-03 | 24,727 | — | $0 | 24,727 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-12-03 | 2020-12-03 | 10,830 | — | $0 | 35,557 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-05-28 | 2020-05-29 | 6,106 | — | $0 | 11,073 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-05-14 | 2020-05-15 | 8,700 | — | $0 | 8,700 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-05-14 | 2020-05-15 | 13,300 | — | $0 | 13,300 | SEC↗ |
| ARAV Aravive, Inc. | D To issuer | 2020-04-08 | 2020-04-09 | 9,291 | — | $0 | 61,201 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-01-15 | 2020-01-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-01-15 | 2020-01-16 | 12,821 | — | $0 | 12,821 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-01-09 | 2020-01-09 | 5,075 | — | $0 | 5,075 | SEC↗ |
| ARAV Aravive, Inc. | F Tax w/h | 2019-12-20 | 2019-12-26 | 2,262 | $11.67 | $26.4K | 70,492 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2019-10-07 | 2019-10-08 | 4,004 | $6.82 | $27.3K | 72,754 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2019-05-29 | 2019-05-31 | 4,967 | — | $0 | 4,967 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2019-05-10 | 2019-05-13 | 1,192 | $6.11 | $7.3K | 76,758 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 116,000 | — | $0 | 116,000 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2019-02-01 | 2019-02-05 | 969 | $4.14 | $4.0K | 82,940 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2019-02-01 | 2019-02-05 | 204 | $4.14 | $845 | 83,909 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2019-02-01 | 2019-02-05 | 990 | $4.14 | $4.1K | 81,950 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2018-12-21 | 2018-12-26 | 3,484 | $3.22 | $11.2K | 84,113 | SEC↗ |
| ARAV Aravive, Inc. | S Sale | 2018-12-17 | 2018-12-19 | 11,247 | $3.96 | $44.5K | 87,597 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-05-24 | 2018-05-29 | 18,700 | — | $0 | 18,700 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 9,232 | $1.50 | $13.8K | 593,066 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2018-02-08 | 2018-02-12 | 14,446 | $1.80 | $26.0K | 602,298 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-12-20 | 2017-12-22 | 223,000 | — | $0 | 616,744 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-10-06 | 2017-10-10 | 189,000 | — | $0 | 393,744 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-05-11 | 2017-05-15 | 9,114 | $17.50 | $159.5K | 204,744 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-27 | 2017-02-28 | 5,166 | — | $0 | 65,828 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-27 | 2017-02-28 | 5,166 | $2.53 | $13.1K | 219,024 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-27 | 2017-02-28 | 5,166 | $24.00 | $124.0K | 213,858 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-23 | 2017-02-23 | 8,000 | — | $0 | 70,994 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-23 | 2017-02-23 | 8,000 | $2.53 | $20.2K | 221,858 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-23 | 2017-02-23 | 8,000 | $20.00 | $160.0K | 213,858 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-21 | 2017-02-23 | 8,000 | — | $0 | 78,994 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-21 | 2017-02-23 | 8,000 | $18.50 | $148.0K | 213,858 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-21 | 2017-02-23 | 8,000 | $2.53 | $20.2K | 221,858 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-03 | 2017-02-06 | 6,719 | $13.69 | $92.0K | 213,858 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-02 | 2017-02-02 | 6,973 | $13.51 | $94.2K | 220,577 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-02 | 2017-02-02 | 4,166 | $2.53 | $10.5K | 227,550 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-01 | 2017-02-02 | 4,166 | — | $0 | 86,994 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-01 | 2017-02-02 | 6,576 | — | $0 | 91,160 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-01 | 2017-02-02 | 6,576 | $2.53 | $16.6K | 229,960 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-01 | 2017-02-02 | 6,576 | $13.95 | $91.7K | 223,384 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-01-31 | 2017-02-02 | 10,662 | — | $0 | 97,736 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-01-31 | 2017-02-02 | 10,662 | $2.53 | $27.0K | 234,046 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-31 | 2017-02-02 | 4,722 | $13.40 | $63.3K | 229,324 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-31 | 2017-02-02 | 5,940 | $14.16 | $84.1K | 223,384 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-01-30 | 2017-01-31 | 10,596 | — | $0 | 108,398 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-30 | 2017-01-31 | 10,596 | $13.31 | $141.0K | 223,384 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-01-30 | 2017-01-31 | 10,596 | $2.53 | $26.8K | 233,980 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-30 | 2017-01-31 | 6,674 | $13.85 | $92.4K | 223,384 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-01-27 | 2017-01-31 | 144,900 | — | $0 | 144,900 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-01-27 | 2017-01-31 | 64,700 | — | $0 | 220,058 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-01-27 | 2017-01-31 | 10,000 | — | $0 | 230,058 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2017-01-17 | 2017-01-19 | 4,500 | — | $0 | 4,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2017-01-17 | 2017-01-19 | 10,500 | — | $0 | 10,500 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2016-08-22 | 2016-08-24 | 5,442 | $12.88 | $70.1K | 155,358 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 7,700 | — | $0 | 7,700 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 3,300 | — | $0 | 3,300 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2016-06-22 | 2016-06-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2016-03-31 | 2016-04-04 | 14,423 | $1.04 | $15.0K | 14,423 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-01-28 | 2016-02-01 | 209,200 | — | $0 | 209,200 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-01-28 | 2016-02-01 | 64,800 | — | $0 | 160,800 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2015-07-20 | 2015-07-22 | 6,300 | — | $0 | 6,300 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2015-06-15 | 2015-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2015-05-11 | 2015-05-13 | 309,000 | — | $0 | 309,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2015-05-11 | 2015-05-13 | 96,000 | — | $0 | 96,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2015-03-26 | 2015-03-30 | 11,111 | — | $0 | 11,111 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2014-09-30 | 2014-10-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2014-06-16 | 2014-06-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2014-03-28 | 2014-04-01 | 14,423 | — | $0 | 14,423 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2013-09-26 | 2013-09-30 | 70,000 | — | $0 | 70,000 | SEC↗ |